From Evidence to Enterprise Value: Positioning HEOR in the Boardroom

Moderator

Clark Paramore, MSPH, Biogen, Cambridge, MA, United States

Speakers

Craig Roberts, MBA, PharmD, Merck, North Wales, PA, United States; Gonçalo Jesus, ViiV Healthcare, London, United Kingdom; Robyn Carson, MPH, AbbVie, Morris Plains, NJ, United States

HEOR leaders are increasingly asked to translate value concepts to C-suite leaders and external audiences who may be less familiar with technical details. Additionally, executives often prioritize financial impact, strategic positioning, and shareholder value, which requires HEOR leaders to adapt their communication strategies. The session will focus on the language and framing necessary to connect HEOR to business initiatives, while emphasizing cross-functional collaboration across any organization. The session will begin with an overview of the different perspectives and the importance of communication, framing, and cross-departmental engagement to strengthen the business case for HEOR evidence (10 minutes, Craig). This will be followed by a discussion across of variety of focus areas including how to effectively communicate and contextualize HEOR outputs to the c-suite, aligning HEOR outputs with broader strategic imperatives to ensure resonance in the boardroom, important communication tools, and tangible examples of HEOR creating business value. Panelists include Craig Roberts (Merck), Goncalo Jesus (Viiv), Robyn Carson (Abbvie), Paulo Carita (Sanofi), Clark Paramore (Biogen). An audience Q&A will follow. Audience members will leave with actionable strategies for translating HEOR into terms that internal executives and non-HEOR external audiences understand, thereby strengthening organizational understanding of HEOR and demonstrating the function as a critical driver of business value.

Topic

Organizational Practices

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×